Krebs Biochemicals & Industries Ltd share price logo

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

BSE: 524518

Small Cap

Pharma Sector

₹58.97

-0.65

(-1.09%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Krebs Biochemicals & Industries shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-54%

Searches for Krebs Biochemicals & Industries on INDmoney have decreased by 54% over the last 30 days.

Krebs Biochemicals & Industries Stock Performance

as on November 11, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹58.00
    ₹60.00
    downward going graph

    1.64%

    Downside

    1.75%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹38.33
    ₹76.85
    downward going graph

    35.00%

    Downside

    30.32%

    Upside

    downward going graph

Krebs Biochemicals & Industries share price movements today

Previous Close
₹59.62
Open
₹58.00
Volume
3,546.00
Upper Circuit
₹71.54
Lower Circuit
₹47.70
Day's Low - High
₹58.00 - ₹60.00
52 Week Low - High
₹38.33 - ₹76.85

Krebs Biochemicals & Industries Historical Returns

1 Month Return
+ 5.26 %
3 Month Return
+ 6.46 %
1 Year Return
-12.18 %
3 Year Return
-29.07 %
5 Year Return
-64.08 %

Krebs Biochemicals & Industries Fundamentals

as on November 11, 2026 at 4:01 pm IST

Market Cap

₹128.54 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-9.29

Return on capital employed (ROCE)

0

Industry PE ratio

53.34

Beta (LTM)

0.92

P/B Ratio

-0.53

Dividend Yield

0

PEG Ratio

-1.42

Quarterly Earnings Growth YOY

-12.05

EPS (TTM)

0

Book Value

0

Krebs Biochemicals & Industries Stock Valuation

as on November 11, 2026 at 4:01 pm IST

Krebs Biochemicals & Industries in the last 5 years

  • Overview

  • Trends

Lowest (-12.83x)

September 21, 2021

Today (-9.29x)

November 8, 2026

Industry (53.34x)

November 8, 2026

Highest (-3.75x)

March 30, 2026

LowHigh

Today’s Price to Earnings Ratio: -9.29x

Krebs Biochemicals & Industries Technical Analysis

Track how Krebs Biochemicals & Industries technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish5
Bullish3
Neutral7

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bullish
CCI (20)
-35.09
Neutral
RSI (14)
44.6
Neutral
Momentum (10)
0
Neutral
ADI (14)
74.26
Neutral
Ultimate Oscillator (7,14,28)
5.71
Bearish

Moving Averages

Name

Value

Action

SMA (20)
58.8
Neutral
EMA (20)
58.8
Bearish
VWMA (20)
58.8
Neutral
SMA (50)
58.8
Neutral
EMA (50)
58.8
Bearish
SMA (200)
58.77
Bullish
EMA (200)
58.86
Bearish
KAMA (200)
58.8
Bearish
DEMA (200)
58.76
Bullish

Krebs Biochemicals & Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Krebs Biochemicals & Industries with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Krebs Biochemicals & Industries Ltd image
Krebs Biochemicals & Industries Ltd
NA128.54-12.82%0.00-1723
Sat Kartar Life Ltd image
Sat Kartar Life Ltd
NA244.91-0.8%0.5217200
Adline Chem Lab Ltd image
Adline Chem Lab Ltd
NA9.2439.58%0.00-1NA
Sotac Pharmaceuticals Ltd image
Sotac Pharmaceuticals Ltd
NA143.651.53%0.716101
Medico Remedies Ltd image
Medico Remedies Ltd
NA156.67-4.4%0.0013206
See all

Krebs Biochemicals & Industries Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
12.98
11.97
12.89
12.86
11.47
6.1
5.48
4.17
7.27
6.81
6.98
5.79
Other Income
0.03
0.21
0.03
0.09
0.25
0.34
0.01
0.01
-
2
0.16
0.04
Total Income
13.01
12.18
12.92
12.94
11.72
6.44
5.49
4.17
7.28
8.81
7.14
5.83
Expenses
15.07
15.09
15.09
15.57
16.18
11.51
7.57
6.96
6.98
7.68
6.16
7.72
Operating Profit
-2.09
-3.12
-2.2
-2.71
-4.71
-5.41
-2.09
-2.79
0.29
-0.87
0.82
-1.93
Operating Profit Margin %
-16.1%
-26.07%
-17.07%
-21.07%
-41.06%
-88.69%
-38.14%
-66.91%
3.99%
-12.78%
11.75%
-33.33%
Profit Before Interest, Tax and Depreciation
-2.06
-2.9
-2.16
-2.62
-4.46
-5.07
-2.08
-2.79
0.3
1.14
0.98
-1.89
Interest
1.19
1.27
1.32
1.42
1.56
1.61
1.65
1.73
1.79
1.91
1.88
1.9
Depreciation
1.73
1.67
1.69
1.71
1.72
1.57
1.6
1.62
1.63
1.57
1.59
1.61
Profit Before Tax
-4.98
-5.84
-5.17
-5.75
-7.74
-8.25
-5.33
-6.14
-3.12
-2.34
-2.49
-5.4
Tax Paid
-
-
-
-
-
0.02
-
-
-
-
-
-
Profit After Tax
-4.98
-5.85
-5.17
-5.76
-7.74
-8.27
-5.32
-6.14
-3.13
-2.34
-2.48
-5.4
Total Net profit including share of profit / Loss from associate company
-4.98
-5.85
-5.17
-5.76
-7.74
-8.27
-5.32
-6.14
-3.13
-2.34
-2.48
-5.4
EPS
-2.31
-2.72
-2.4
-2.67
-3.59
-3.83
-2.47
-2.85
-1.45
-1.09
-1.15
-2.5
Actual EPS
-2.31
-2.72
-2.4
-2.67
-3.59
-3.83
-2.47
-2.85
-1.45
-1.09
-1.15
-2.5
Adjusted EPS
-2.31
-2.72
-2.4
-2.67
-3.59
-3.83
-2.47
-2.85
-1.45
-1.09
-1.15
-2.5
Diluted EPS
-2.31
-2.72
-2.4
-2.67
-3.59
-3.83
-2.47
-2.85
-1.45
-1.09
-1.15
-2.5

Krebs Biochemicals & Industries Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
25.38
37.13
23.58
38.61
59.7
52.13
50.42
43.31
23.73
Other Income
0.35
0.44
0.37
0.62
1.16
0.62
0.45
0.71
2.03
Total Income
34.13
48.2
33.78
54.32
60.86
52.75
50.87
44.02
25.76
Expenses
42.64
57.57
52.04
71.28
93.7
67.91
59.15
58.34
29.18
Operating Profit
-17.26
-20.44
-28.46
-32.67
-34
-15.78
-8.73
-15.03
-5.45
Operating Profit Margin %
-68.01%
-55.05%
-120.7%
-84.62%
-56.95%
-30.27%
-17.31%
-34.7%
-22.97%
Profit Before Interest, Tax and Depreciation
-8.51
-9.37
-18.27
-16.96
-32.84
-15.16
-8.27
-14.32
-3.42
Interest
5.17
6.24
5.93
6.28
5.39
2.97
4.69
5.91
7.09
Depreciation
4.15
4.4
4.68
5.12
6.3
6.56
6.77
6.69
6.42
Profit Before Tax
-17.83
-20.01
-28.88
-28.36
-44.53
-24.69
-19.73
-26.92
-16.93
Tax Paid
-
-
-
-
-
-
-
0.02
-
Profit After Tax
-17.82
-20.01
-28.87
-28.36
-44.53
-24.69
-19.73
-26.94
-16.93
Total Net profit including share of profit / Loss from associate company
-17.82
-20.01
-28.87
-28.36
-44.53
-24.69
-19.73
-26.94
-16.93
EPS
-14.01
-12.83
-17.9
-14.37
-20.81
-11.3
-9.16
-12.49
-7.85
Actual EPS
-14.01
-12.83
-17.9
-14.37
-20.81
-11.3
-9.16
-12.49
-7.85
Adjusted EPS
-13.53
-12.83
-17.9
-14.37
-20.81
-11.3
-9.16
-12.49
-7.85
Diluted EPS
-14.01
-15.46
-17.9
-14.37
-20.81
-11.3
-9.16
-12.49
-7.85

Krebs Biochemicals & Industries Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
-15.26
-11.2
-6.19
3.9
-35.5
-14.57
-17.22
-24.71
2.36
-7.89
-1.92
Cash Flow from Investing Activities
6.54
-11.73
-4.09
-4.87
-9.51
-14.8
-26.46
-16.93
-7.82
-4.97
-3.64
Cash Flow from Financing Activities
13.22
15.75
9.26
17.32
28.58
37.66
39.5
37.35
5.5
12.87
5.54
Net Cash Flow
-6.04
-0.15
0.3
16.9
-17.14
0.54
-0.61
-0.01
0.05
-
-0.01

Krebs Biochemicals & Industries Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
72.74%
72.74%
72.74%
72.74%
72.74%
72.74%
72.74%
72.74%
72.74%
72.74%
72.74%
72.74%
FII
0.01%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
0%
0.5%
0.5%
0.5%
Public
26.76%
26.76%
26.76%
26.76%
26.76%
26.76%
26.76%
26.76%
26.76%
26.76%
26.76%
26.76%
Total Outstanding Shares
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
2,15,60,586
Total Shareholders
8,990
8,909
8,848
9,425
9,091
8,798
9,118
8,912
8,710
8,553
8,521
8,533

Krebs Biochemicals & Industries Corporate Actions

View detailed summary of the earnings and dividend history of Krebs Biochemicals & Industries.

  • Krebs Biochemicals & Industries Ltd Earnings Results

    Krebs Biochemicals & Industries Ltd’s net profit jumped 12.05% since last year same period to ₹-5.40Cr in the Q2 2026-2027. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated -117.74% fall in its net profits since last 3-months.

    Read More

Insights on Krebs Biochemicals & Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KREBSBIO stock has moved up by 4.4%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 26.76% of holdings in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 560.9% return, outperforming this stock by 590.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.74% of holdings in Sep 2026 quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.49% of holdings in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Laurus Labs Ltd has given 149.0% return, outperforming this stock by 161.1%

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals Industries Ltd. (KBIL) is a fermentation-based active pharmaceutical ingredient (API) manufacturer. Established in 1991, KBL has grown to a capacity of 150 TPA since launching its commercial operations in 1994. KBL has developed global capabilities in fermentation technology, resulting in successful launches over a two-year period (200102) of Vitamin CIP Grade via fermentation. The company has ISO 9002 certifications for its unit I at Nellore and produces and markets Lovastatin, Simvastatin, and Vitamin C. KBL is also in the process of building a cogeneration power plant at unit II. It has also successfully bidded for Nannapaneni Venkatrao Cooperative Sugars Ltd located at Jampani, Guntur District, Andhra Pradesh in December 2003.

Revenue: ₹5.79Cr as on September 2026 (Q2 FY27)
Net Profit: ₹-5.40Cr as on September 2026 (Q2 FY27)
Listing date: 28 Aug, 1995
Chairperson Name: R T Ravi
OrganisationKrebs Biochemicals & Industries Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOR T Ravi
E-voting on sharesClick here to vote

FAQs

What is Krebs Biochemicals & Industries share price today?

Krebs Biochemicals & Industries share price today stands at ₹58.97 as on at the close of the market. Krebs Biochemicals & Industries share today touched a day high of ₹60 and a low of ₹58.

What is the 52 week high and 52 week low range for Krebs Biochemicals & Industries share?

Krebs Biochemicals & Industries touched a 52 week high of ₹76.85 and a 52 week low of ₹38.33. Krebs Biochemicals & Industries share price today i.e. is closed at ₹58.97, which is -23.27% down from its 52 week high and 53.85% up from its 52 week low.

What is Krebs Biochemicals & Industries's market capitalisation today?

Krebs Biochemicals & Industries market capitalisation is ₹128.54 Cr as on .

How to buy Krebs Biochemicals & Industries shares?

To buy Krebs Biochemicals & Industries shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KREBSBIO or Krebs Biochemicals & Industries Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Krebs Biochemicals & Industries shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Krebs Biochemicals & Industries trading volume today?

Krebs Biochemicals & Industries trading volume is 3,546.00 as on . This means that 3,546.00 shares of Krebs Biochemicals & Industries were bought and sold on the stock market during today's trading session.